January 22, 2021
Japan’s regulator approves Grifols’ Lynspad™ [alpha-1 proteinase inhibitor] for the treatment of alpha-1 antitrypsin deficiency
January 18, 2021
Grifols begins clinical trial of a new treatment that would provide immediate immunity against COVID-19
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?